The Arab Health Conference and Exhibition currently taking place in Dubai revealed a device in the shape of a smart cap designed to treat depression, obsessive-compulsive disorder (OCD), and assist with smoking cessation. This cap is the first of its kind globally, distinguished by its use of artificial intelligence and transcranial magnetic stimulation, targeting deeper regions of the brain cortex.
The device garnered public interest and inquiries at the exhibition regarding its benefits for other mental health conditions. Dr. Ammar Martini, a board member at the Gilan Medical Foundation, stated that "the new device utilizes innovative, non-invasive, and proven technology that is applied in a seated position in a clinic, without pain, discomfort, or side effects post-treatment."
On Thursday, Martini informed journalists that the device has received approval from the U.S. Food and Drug Administration and European quality certification, both of which are among the highest global health institutions concerned with registration and accreditation. He explained that the device aims to change the mental state of individuals suffering from depression, OCD, or those looking to quit smoking.
The technology behind the device involves transcranial magnetic stimulation that targets deep brain areas by exposing them to a magnetic field, which stimulates or inhibits deep neural cell areas in the brain. The device stimulates brain regions to address severe depression by activating the left dorsal lateral prefrontal cortex, OCD by stimulating the anterior cingulate cortex, and aids in smoking cessation by activating the prefrontal cortex and insular cortex.
This technology stimulates neurons in the brain to a depth of up to 3.2 cm, covering a larger area to achieve the best results from treatment sessions. A specific helmet is used to reach greater depths and cover more area for optimal outcomes.
Regarding the advantages and benefits of this technology compared to traditional methods, Dr. Ammar Martini indicated that some patients cannot tolerate medications due to side effects associated with depression, anxiety, weight gain, sexual dysfunction, suicidal thoughts, nausea, and insomnia. He noted that numerous studies have demonstrated a better response rate among individuals treated with this technology, enabling them to return to their normal lives.
